Salarius Pharmaceuticals files prospectus supplement for up to $335,921 ATM stock offering

Decoy Therapeutics Inc.

Offering of up to $335,921 in common stock under existing ATM agreement with Ladenburg Thalmann & Co. Inc.
Prospectus supplement filed on July 25, 2024, under effective registration statement (File No. 333-266589).
Legal opinion of Hogan Lovells US LLP on share validity attached as Exhibit 5.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.